InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| FLA-ST (Standard or Ultrapure) | A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneu... | 2021 | PLoS One | Maguire P.M. et al. | DOI: 10.1371/journal.pone.0258261 |
| ODN 2216 - TLR9 ligand | A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneu... | 2021 | PLoS One | Maguire P.M. et al. | DOI: 10.1371/journal.pone.0258261 |
| Plasmocin® - Mycoplasma Elimination Reagent | Phosphor-IWS1-dependent U2AF2 splicing regulates trafficking of CAR-E-positiv... | 2021 | Commun Biol. | Laliotis G.I. et al. | DOI: 10.1038/s42003-021-02668-z |
| pFUSE-CHIg-hG1 | HMGB1 signaling phosphorylates Ku70 and impairs DNA damage repair in Alzheime... | 2021 | Commun Biol. | Tanaka H. et al. | DOI: 10.1038/s42003-021-02671-4 |
| pFUSE2-CLIg-hK | HMGB1 signaling phosphorylates Ku70 and impairs DNA damage repair in Alzheime... | 2021 | Commun Biol. | Tanaka H. et al. | DOI: 10.1038/s42003-021-02671-4 |
| Puromycin | A role for AKT1 in nonsense-mediated mRNA decay. | 2021 | Nucleic Acids Res. | Palma M. et al. | DOI: 10.1093/nar/gkab882 |
| pVITRO2-MCS | Identification and Characterization of a Novel Single Domain Antibody Against... | 2021 | Virol Sin. | Wang R. et al. | DOI: 10.1007/s12250-021-00454-z |
| Poly(I:C) (HMW) VacciGrade™ | A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irra... | 2021 | Virol J. | Sabbaghi A. et al. | DOI: 10.1186/s12985-021-01672-3 |
| Anti-hTLR4-IgG | The soluble cytoplasmic tail of CD45 regulates T cell activation via TLR4 sig... | 2021 | Eur J Immunol. | Puck A. et al. | DOI: 10.1002/eji.202149227 |
| QUANTI-Blue™ | Next generation of tumor-activating type I IFN enhances anti-tumor immune res... | 2021 | Nat Commun. | Cao X. et al. | DOI: 10.1038/s41467-021-26112-2 |
| QUANTI-Luc™ | Next generation of tumor-activating type I IFN enhances anti-tumor immune res... | 2021 | Nat Commun. | Cao X. et al. | DOI: 10.1038/s41467-021-26112-2 |
| 293-Dual™ hSTING-R232 Cells | Next generation of tumor-activating type I IFN enhances anti-tumor immune res... | 2021 | Nat Commun. | Cao X. et al. | DOI: 10.1038/s41467-021-26112-2 |
| CR3022-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes | Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-ne... | 2021 | J Exp Med | Shinnakasu R. et al. | DOI: 10.1084/jem.20211003 |
| AddaVax™ | Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-ne... | 2021 | J Exp Med | Shinnakasu R. et al. | DOI: 10.1084/jem.20211003 |
| PMA | Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Parti... | 2021 | J Innate Immun | Maruyama K. et al. | DOI: 10.1159/000518953 |
| NLRP3 KO & KD THP-1 Cells | Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Parti... | 2021 | J Innate Immun | Maruyama K. et al. | DOI: 10.1159/000518953 |
| THP1-Null Cells | Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Parti... | 2021 | J Innate Immun | Maruyama K. et al. | DOI: 10.1159/000518953 |
| ASC Knockout & Knockdown Monocytes | Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Parti... | 2021 | J Innate Immun | Maruyama K. et al. | DOI: 10.1159/000518953 |
| MSU Crystals | Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Parti... | 2021 | J Innate Immun | Maruyama K. et al. | DOI: 10.1159/000518953 |
| LPS-EK (LPS from E. coli K12) | Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Parti... | 2021 | J Innate Immun | Maruyama K. et al. | DOI: 10.1159/000518953 |